四种设备,一种解决方案:金心脏再同步疗法与除器在一个病人与过敏过敏
Rahul Devathu1, Kushal Chatterjee1, Erick Godinez2
1Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
概括
过敏可以导致CIED并发症. 一个定制的金设备在多次设备故障后成功管理了一名患者,改善了心脏功能.
科学领域:
- 心脏病学 心脏病学
- 生物材料科学 生物材料科学
- 过敏和免疫学 过敏和免疫学
背景情况:
- 过敏是心脏植入式电子设备 (CIED) 患者罕见但重要的并发症原因.
- 对的反应可以模仿设备感染,导致错误诊断和重复的设备爆炸.
- 尽管具有一般的生物相容性,但患者的特定敏感性会给临床带来挑战.
研究的目的:
- 报告一个由于过敏导致的CIED复发症患者的成功管理情况.
- 突出在CIED患者中诊断和管理过敏的挑战.
- 为了证明替代设备材料在耐火情况下的实用性.
主要方法:
- 一名67岁的男性患有非缺血性心肌病,由于对过敏而经历了多次CIED失败.
- 以前使用高尔-德克斯包装的尝试在缓解过敏方面没有成功.
- 根据FDA的同情使用条款,植入了一种定制的金心脏再同步治疗与除器 (CRT-D) 设备.
主要成果:
- 患者通过右侧方法获得金的CRT-D.
- 在一年的随访中,手术部位愈合良好,没有复发的并发症或不适.
- 左心室喷射分数 (LVEF) 显著改善,从植入后的29%提高到50%.
结论:
- 这一案例凸显了与CIED接受者的过敏相关的诊断困难.
- 对于过敏的传统管理策略可能是有限的.
- 跨学科的合作对于导航监管途径和提供特定的患者,使用替代材料提供持久的解决方案至关重要.
相关概念视频
Cardiomyopathy II: Dilated Cardiomyopathy
427
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
427
Cardiomyopathy III: Hypertrophic Cardiomyopathy
354
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
354
Heart Failure VI: Adjunct Therapies
228
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
228
Cardiopulmonary Resuscitation III: AED Use
473
Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
473
Heart Failure Drugs: Inotropic Agents
1.2K
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.2K
Cardiomyopathy V: Interprofessional Care
305
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
305


